IBS.Granada
Granada, Spain
NCT Number: NCT05443880
Chronic low back pain is among the most common health problems seen in primary care, and is responsible for disability and absenteeism in our country. In most cases, it is attributed to a non-specific cause and classified as non-specific chronic low back pain (NSCLBP). Taking into consideration that multidimensional programs usually present more effectiveness reducing pain than unimodal programs, the current research investigates the role of unexplored multidimensional program (exercise and mindfulness) in NSCLBP. The primary aim of this project is to determine the effectiveness of a supervised exercise program (intervention 1) and a supervised exercise program + mindfulness (intervention 2) on pain, disability, trunk muscle endurance/strength, quality of life and gait parameters in patients with NSCLBP.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Granada, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The exercise intervention will focus on working the core muscles, starting with low-intensity isometric contraction of the core muscles that stabilize the trunk; increasing intensity by performing functional tasks (phase 1: independent isometric contraction of transversus-abdominis and multifidus, phase 2: co-contraction and functional tasks of the deep trunk muscles; phase 3: functional task with load; phase 4: functional task with unstable surface)
The Mindfulness Based Stress Reduction (MBSR) program will strictly follow the protocol developed by Jon Kabat Zinn. Each session will include three activities: the presentation of a topic, moments of dialogue and exploration in group (using appreciative inquiry) and a Mindfulness practice. Participants will be provided with workbooks, audios with guided meditations, and instructions for practice at home. In addition, the Exercise + mindfulness intervention will include the exercise program described in the exercise intervention.
The control group will be provided with the usual care received in the Physical Medicine and Rehabilitation Service: stretching, breathing and motor control exercises 2 days / week (45 minutes per session) during a period of 8 weeks.
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be measured with the Biering-Sørensen test and the plank test.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be measured with the Biering-Sørensen test and the plank test.
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be measured by the 30s chair stand test. Upper body strength (maximal isometric strength) will be measured with the handgrip strength test (TKK dynamometer).
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be measured by the 30s chair stand test. Upper body strength (maximal isometric strength) will be measured with the handgrip strength test (TKK dynamometer).
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be measured with the handgrip strength test (TKK 5101 Grip-D; Takey, Tokyo, Japan dynamometer).
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be measured with the handgrip strength test (TKK 5101 Grip-D; Takey, Tokyo, Japan dynamometer).
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be measured using a hand-held standard pressure algometer (FPK 20, Wagner Instruments, Greenwich, CT, USA).
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be measured using a hand-held standard pressure algometer (FPK 20, Wagner Instruments, Greenwich, CT, USA).
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be assessed with the Oswestry low back pain scale. The total score will be calculated summing the value of the 10 items and represented as percentage (%), where 0-20% means minimum functional limitation; 20%-40% moderate functional limitation; 40%-60% intense functional limitation; 60%-80% disability and more than 80% maximum functional limitation.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be assessed with the Oswestry low back pain scale. The total score will be calculated summing the value of the 10 items and represented as percentage (%), where 0-20% means minimum functional limitation; 20%-40% moderate functional limitation; 40%-60% intense functional limitation; 60%-80% disability and more than 80% maximum functional limitation.
Time frame: Change from baseline at 2 months (Postest minus Retest)
Patients will be instructed to indicate the intensity of pain they felt on a valid and reliable 10 cm long straight line marked with a score from 0 to 10
Time frame: Change from baseline at 5 months (Retest minus Pretest)
Patients will be instructed to indicate the intensity of pain they felt on a valid and reliable 10 cm long straight line marked with a score from 0 to 10
Time frame: Change from baseline at 2 months (Postest minus Retest)
They will be recorded through GT3X+ Accelerometer (Actigraph, Inc., Fort Walton Beach, FL, USA).
Time frame: Change from baseline at 5 months (Retest minus Pretest)
They will be recorded through GT3X+ Accelerometer (Actigraph, Inc., Fort Walton Beach, FL, USA).
Time frame: Change from baseline at 2 months (Postest minus Retest)
Spatiotemporal parameters (e.g., cadence, stance and support times, step length and stride width) will be calculated using Optogait.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
Spatiotemporal parameters (e.g., cadence, stance and support times, step length and stride width) will be calculated using Optogait.
Time frame: Change from baseline at 2 months (Postest minus Retest)
will be measured by bioelectrical impedance analysis (InBody R20, Biospace)
Time frame: Change from baseline at 5 months (Retest minus Pretest)
will be measured by bioelectrical impedance analysis (InBody R20, Biospace)
Time frame: Change from baseline at 2 months (Postest minus Retest)
they will be measured by bioelectrical impedance analysis (InBody R20, Biospace) and height rod (Seca 22).
Time frame: Change from baseline at 5 months (Retest minus Pretest)
they will be measured by bioelectrical impedance analysis (InBody R20, Biospace) and height rod (Seca 22).
Time frame: Change from baseline at 2 months (Postest minus Retest)
will be assessed with the Short-Form Health Survey (SF-36). It contains 36 items grouped into 8 dimensions: physical functioning, physical role, body pain, general health, vitality, social functioning, emotional role, and mental health. The scores range from 0 to 100 in every dimension, where higher scores indicate better health.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
will be assessed with the Short-Form Health Survey (SF-36). It contains 36 items grouped into 8 dimensions: physical functioning, physical role, body pain, general health, vitality, social functioning, emotional role, and mental health. The scores range from 0 to 100 in every dimension, where higher scores indicate better health.
Time frame: Change from baseline at 2 months (Postest minus Retest)
The Central Sensitisation Inventory will be used. It is a self-report questionnaire designed to identify patients who have symptoms that may be related to central sensitisation. It presents 25 questions and the patient scores each answer on a scale of 0 (never) to 4 (always). A score of more than 40 indicates the presence of central sensitisation
Time frame: Change from baseline at 5 months (Retest minus Pretest)
The Central Sensitisation Inventory will be used. It is a self-report questionnaire designed to identify patients who have symptoms that may be related to central sensitisation. It presents 25 questions and the patient scores each answer on a scale of 0 (never) to 4 (always). A score of more than 40 indicates the presence of central sensitisation
Time frame: Change from baseline at 2 months (Postest minus Retest)
The Pain Catastrophizing Scale will be used to assess painful experiences and thoughts or feelings about pain. It contains 13 items on a 5-point scale. Higher score represents a more negative appraisal of pain.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
The Pain Catastrophizing Scale will be used to assess painful experiences and thoughts or feelings about pain. It contains 13 items on a 5-point scale. Higher score represents a more negative appraisal of pain.
Time frame: Change from baseline at 2 months (Postest minus Retest)
The Beck Depression Inventory-II will be used. It contains 21 items and the range of score is 0-63 with higher values indicating greater depression.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
The Beck Depression Inventory-II will be used. It contains 21 items and the range of score is 0-63 with higher values indicating greater depression.
Time frame: Change from baseline at 2 months (Postest minus Retest)
The State Trait Anxiety Inventory-I will be used to assess anxiety state (i.e., the level of current anxiety). It is a 20-item self-administered questionnaire and the range of score is 20-80, with higher score indicating a greater anxiety state.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
The State Trait Anxiety Inventory-I will be used to assess anxiety state (i.e., the level of current anxiety). It is a 20-item self-administered questionnaire and the range of score is 20-80, with higher score indicating a greater anxiety state.
Time frame: Change from baseline at 2 months (Postest minus Retest)
It will be assessed with the Pittsburgh Sleep Quality Index. It is composed of 19 questions, with four-point Likert scales (0-3), addressing seven components: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, sleep medication, and daytime dysfunction. The sleep quality global score is the sum of all components. Higher scores indicate worse sleep quality.
Time frame: Change from baseline at 5 months (Retest minus Pretest)
It will be assessed with the Pittsburgh Sleep Quality Index. It is composed of 19 questions, with four-point Likert scales (0-3), addressing seven components: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, sleep medication, and daytime dysfunction. The sleep quality global score is the sum of all components. Higher scores indicate worse sleep quality.
IBS Granada
Other
Multidimensional Approach (Exercise and Mindfulness) for Health Improvement in Patients With Non-specific Chronic Low Back Pain: The BackFit Project
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03974191
Back Pain, Behavior
Alingsås, Sweden
View Trial DetailsNCT06114264
Back Pain, Behavior
Granada, Spain
View Trial DetailsNCT03986047
Acute Pain, Back Pain
Québec, Quebec, Canada
View Trial DetailsNCT07281183
Back Pain, Behavior
Istanbul, Turkey (Türkiye)
View Trial Details